Format

Send to

Choose Destination
J Clin Invest. 1999 Dec;104(11):1503-6.

Choosing anticancer drug targets in the postgenomic era.

Author information

1
Dana-Farber Cancer Institute, 44 Binney Street, Mayer 457, Boston, Massachusetts 02115, USA. william_kaelin@dfci.harvard.edu
PMID:
10587513
PMCID:
PMC409873
DOI:
10.1172/JCI8888
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center